Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine.

Guo, Yuna; Jia, Wenshuang; Yang, Jingru; Zhan, Xianquan

Guo, Yuna; Jia, Wenshuang; Yang, Jingru; Zhan, Xianquan.

Afiliação

Guo Y; Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Jinan, China.
Jia W; Medical Science and Technology Innovation Center, Shandong First Medical University, Jinan, China.
Yang J; Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Jinan, China.
Zhan X; Medical Science and Technology Innovation Center, Shandong First Medical University, Jinan, China.

Front Endocrinol (Lausanne) ; 13: 970489, 2022.

Article em En | MEDLINE | ID: mdl-36072925

Assuntos

Glicômica; Neoplasias; Biomarcadores/metabolismo; Glicoproteínas/metabolismo; Glicosilação; Humanos; Neoplasias/diagnóstico; Neoplasias/metabolismo; Neoplasias/terapia; Polissacarídeos

Palavras-chave

3P medicine; cancer biomarker; fluorescence imaging; glycosylation; immunochemical method; immunotherapy; lectin recognition; mass spectrometry

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicômica / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google